|

Positive Affect Treatment for Adolescents with Early Life Adversity

RECRUITINGN/ASponsored by University of California, Irvine
Actively Recruiting
PhaseN/A
SponsorUniversity of California, Irvine
Started2024-02-03
Est. completion2030-10-31
Eligibility
Age12 Years – 16 Years
Healthy vol.Accepted
Locations1 site

Summary

Youth exposed to early life adversity (ELA) are known to be at greater risk for depression and suicidality and account for almost half of the youth suffering from psychiatric diseases today. Youth exposed to ELA consistently report symptoms of anhedonia as well as dysregulated positive affect. The present project will test the efficacy of PAT in a sample of ELA-exposed adolescents in order to determine whether PAT increases positive affect, and subsequently symptoms of depression. For the initial pilot phase of the investigation, the investigators will recruit up to 30 adolescents exposed to two or more childhood adversities (ACEs) who do not currently have major depressive disorder, and randomize them (1:1) to either participate in PAT or a waitlist control condition. For the second phase of the investigation, the investigators will recruit up to 300 adolescents exposed to two or more childhood adversities (ACEs) who do not currently have major depressive disorder, and randomize them (1:1) to either participate in PAT or supportive psychotherapy. For both phases, at study enrollment, then 4-, 8, and 12-months thereafter the investigators will measure positive affect and depressive symptoms (including anhedonia and reward sensitivity). The results of this study will be used to inform whether PAT has the potential to prevent major depressive episodes among adversity-exposed youth.

Eligibility

Age: 12 Years – 16 YearsHealthy volunteers accepted
Inclusion Criteria:

* aged 12-16
* exposed to 2 or more adverse childhood experiences (ACEs)

Exclusion Criteria:

* currently taking an antidepressant or any medications known to influence immune functioning on a daily basis (e.g., steroidal medications to treat asthma or allergies)
* current or past history of manic or psychotic symptoms
* parent-reported diagnosis of intellectual disability or autism spectrum disorder
* chronic medical conditions (e.g., cancer, rheumatoid arthritis, diabetes, multiple sclerosis),
* bleeding disorders such as hemophilia

Conditions1

Depression

Locations1 site

University of California Irvine
Irvine, California, 92617
Kate R Kuhlman9498245574krkuhl@uci.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.